• Facebook
  • Rss
  • Twitter
  • Youtube
  • Store
  • Donate
NCCS - National Coalition for Cancer Survivorship
  • About
    • Our Mission
    • Our History
    • Our Leadership
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Survivorship Champions
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Cancer Convos Podcast
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • Ellen L. Stovall Award
      • Nominations
      • Honorees
      • Sponsors
      • Committees
    • From Shadows to Life: A Biography of the Cancer Survivorship Movement
    • Cancer Policy Roundtable
      • Spring 2021 Cancer Policy Roundtable
      • Fall 2020 Cancer Policy Roundtable
      • Spring 2020 Cancer Policy Roundtable
    • Cancer Policy and Advocacy Team (CPAT) Symposium 2020
    • Webinars
  • Contact Us
  • Search
  • Menu Menu
  • 0Shopping Cart

Year-End MATCH (DEADLINE Dec 31): Donate & Make a Difference | Donate

20years

Cancer Survivorship: You’re Never Really Done

July 28, 2015/in Cancer News, Cancer Policy Blog Care Planning, Quality Cancer Care, Survivorship Care NCCS News /by actualize
Ellen Stovall

Post By Ellen Stovall, Senior Health Policy Advisor and 42-Year Survivor

When the Imperatives of Quality Cancer Care were written by NCCS 20 years ago, one principle of quality care stated that, “Long-term survivors should have access to specialized follow-up clinics that focus on health promotion, disease prevention, rehabilitation, and identification of physiologic and psychological problems. Communication with the primary care physician must be maintained.”

It was NCCS’s vision two decades ago that there would be enough evidence to support access to and insurance coverage for interventions for short and long-term survivors related to promoting health, preventing disease, and both physical and psychosocial rehabilitation. In 2015, we are happily closer to realizing some parts of that vision, but far from able to implement it across all populations and inclusive of all settings where post-treatment cancer care is offered.

Like most of us treated for cancer, being finished with treatment is simply another stage of what we call survivorship—the act of living with, through, and beyond the diagnosis. In fact, cancer survivorship from diagnosis through the end of life has its own roadmaps fraught with much uncertainty. Each of the more than 14 million cancer survivors among us has their own story of survivorship.

“What most people diagnosed with cancer want is to be cured; what few oncologists and their patients understand or even want to discuss are the consequences of those treatments and how they should be managed.”

As a 24 year-old wife and mother to our four-week old son, Jonathan (he is now 43), I was diagnosed with Hodgkin’s Lymphoma in 1971. Following surgery and six months of radiation, a recurrence of the same diagnosis appeared 12 years later followed by a diagnosis of bilateral breast cancer seven years ago, resulting in a double mastectomy. Those are my cancer diagnoses. And then there comes daily living with a heart, lungs, kidneys, bones and tissues that look and feel like those of someone 20 years older than my chronological years. These clinical and psychological adjustments that most of us survivors experience are little discussed.

What most people diagnosed with cancer want is to be cured; what few oncologists and their patients understand or even want to discuss are the consequences of those treatments and how they should be managed. This is the world of cancer survivorship, and that population of survivors grows exponentially every day. Knowing there are short and long-term consequences of those treatments is part of the planning for survivorship that must begin at diagnosis. Choosing treatments with fewer long-term effects or intervening to prevent some of those effects is also needed.

I am a privileged cancer survivor. I have access to a specialized follow-up clinic, but have been less successful in having my many specialists communicate with one another to determine the best surveillance and course of ongoing interventions that may be needed. Consequently, I remain one of many survivors who are captive to a healthcare system where duplicate tests are ordered and there is little, if any, coordination of care among my physicians. And so I created my own plan for follow-up care, which at the time of my diagnosis was limited to clinical guidelines that said I should have CT scans and bloodwork every 3 months; then 6 months; and then yearly “for the rest of my life.” Just what I needed—more radiation exposure—but in fact, these procedures were defined as “appropriate follow-up care.”

As it turns out, my first recurrence with Hodgkin’s Lymphoma was diagnosed after I had symptoms that I instinctively knew were reminiscent of how I felt when I was first diagnosed. I had a hard time convincing my oncologist that I was ill, and only after persistent nagging for him to do more tests was the recurrence discovered. This is not an uncommon story among my fellow survivors. It was at this time on my own path of post-treatment care that I began an earnest investigation into long-term survivorship care. There was not a lot to read about, with only a handful of researchers even interested in the topic.

I began to cobble together all of my medical records and to write my own care plan. I summarized everything that had happened to me in the 12 years since my original diagnosis onto one page and, along with a list of every medicine, etc., took this information to any new doctor who saw me. I requested that a new doctor “consult” with my oncologist before prescribing any new treatments. I expect I may have been described as a “challenging” or “difficult” patient, despite how polite I considered myself to be.

Over the years, advocacy on the part of many organizations has made follow-up care for cancer survivors, less of a “one-off” notion. The exercise of shared decision-making and care planning is being brought into discussions regarding new delivery and payment models for cancer care among physicians and third-party payers of healthcare. What follows is a graphic illustration of the care planning process. While we may not realize the full vision of follow-up clinics to deliver this care, we are beginning to see a systematic incorporation of some essential elements of best practices in the processes for making important decisions about our treatment options when we are first diagnosed. This will go a long way towards mitigating some of the late effects of cancer treatment.

care coordination complexities

This diagram illustrates the complexity of cancer care coordination. With clinical, procedural, and other supportive office visits, cancer patients may need to coordinate care with additional members of their care team, including a nurse navigator, a psychotherapist, occupational therapist, neurologist, hematologist, gynecologist, urologist, pulmonologist, or other providers. This diagram is adapted from “Ambulatory Care Coordination for One Patient” from Instant Replay — A Quarterback’s View of Care Coordination, a perspective piece by Matthew J. Press, M.D.


Read more posts from our 20 Years Later blog series »

Tags: 20 Years Later, by Ellen Stovall, cancer care, Cancer Survivorship, care planning, Ellen Stovall, patient first, quality
Share this entry
  • Share on Facebook
  • Share on Twitter
https://canceradvocacy.org/wp-content/uploads/2015/01/20years.gif 500 500 actualize https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png actualize2015-07-28 10:19:132015-07-28 10:19:13Cancer Survivorship: You’re Never Really Done
You might also like
NCCS Starburst Thumbnail WCOE: Life-saving End-of-life Discussions, New HHS Investment, When Seniors Talk to Med Students, and More
FacebookProfile3 ASCO announces new Cancer Survivorship Booklet – download now!
NCCS News Cancer Policy Matters NCCS Applauds Introduction by Reps. DeSaulnier and Carter of Bipartisan “Cancer Care Planning and Communications Act”
FacebookProfile3 Cancer Patients Should Be Wary of Needless Tests and Treatments
Dome Thumbnail starburst NCCS Policy Comments: Recommending Cancer Survivorship as a Topic for FDA Patient-Focused Drug Development Meetings
New York Times Thumbnail New York Times Opinion Piece Describes Common Disparities in Communication and Comprehension
HoffmanThumbnail The National Cancer Legal Services Network Discusses How to Address Legal Needs of Survivors
FacebookProfile3 The Many Shades of Survivorship

Latest News

NCCS Founders at 1990 Assembly

The Birth of the Cancer Survivorship Movement and How It Transformed Cancer Care for Millions

March 25, 2021
Guest Post by Judith L. Pearson Best-Selling Author of From Shadows to Life: A Biography…
Read more
https://canceradvocacy.org/wp-content/uploads/2018/02/10-Founders-1990-NCCS-Assembly.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2021-03-25 10:36:202021-03-25 13:46:05The Birth of the Cancer Survivorship Movement and How It Transformed Cancer Care for Millions
HHS Humphrey bldg 1200

Biden Rescinds Trump Admin Proposal to Limit Medicare Part D Coverage of Drugs in “Six Protected Classes”

March 19, 2021
This week, the Biden administration rescinded a Trump administration-proposed plan…
Read more
https://canceradvocacy.org/wp-content/uploads/2017/10/HHS-Humphrey-bldg-1200.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2021-03-19 13:36:192021-03-23 14:46:18Biden Rescinds Trump Admin Proposal to Limit Medicare Part D Coverage of Drugs in “Six Protected Classes”
CDC Headquarters

NCCS Recommends That States Allocate COVID-19 Vaccines to Cancer Care Providers

March 1, 2021
The National Coalition for Cancer Survivorship (NCCS) and the Cancer Leadership Council…
Read more
https://canceradvocacy.org/wp-content/uploads/CDC_Headquarters_PHIL_pubdomain_1200.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2021-03-01 15:49:432021-03-04 17:45:07NCCS Recommends That States Allocate COVID-19 Vaccines to Cancer Care Providers

Take Action

Stovall Award

The Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care is a unique opportunity for patients and survivors to recognize pioneers who are transforming the cancer care system.

Join CPAT

The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.

Share Your Story

NCCS represents the millions of Americans who share a common experience – the survivorship experience – living with, through and beyond a cancer diagnosis.

STAY CONNECTED

Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action

  • About
    • Our Mission
    • Our History
    • Our Leadership
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Survivorship Champions
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Cancer Convos Podcast
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • Ellen L. Stovall Award
      • Nominations
      • Honorees
      • Sponsors
      • Committees
    • From Shadows to Life: A Biography of the Cancer Survivorship Movement
    • Cancer Policy Roundtable
      • Spring 2021 Cancer Policy Roundtable
      • Fall 2020 Cancer Policy Roundtable
      • Spring 2020 Cancer Policy Roundtable
    • Cancer Policy and Advocacy Team (CPAT) Symposium 2020
    • Webinars
  • Contact Us

National Coalition for Cancer Survivorship
8455 Colesville Road  |  Suite 930  |  Silver Spring, MD 20910
877-NCCS-YES  |  info@canceradvocacy.org
Privacy Policy  |  Terms and Conditions

Copyright © 1995-2021 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.

Guest Video: Mary McCabe Discusses Survivorship Care Planning and the Delivery... 20years Fotolia 73341760 S Guest Post Series: Dr. John Cox Offers Physician’s Perspective on Oncology...
Scroll to top

Harmar Brereton, MD

Founder
Northeast Regional Cancer Institute

 

“Perhaps one of the most impactful collaborations in Dr. Brereton’s extraordinary career remains his early work and long friendship with Ellen Stovall. Through him, and in turn through the thousands of lives he has touched, Ellen’s work continues, and her mission lives on.”

—Karen M. Saunders
President, Northeast Regional Cancer Institute